Population pharmacokinetics of metronidazole evaluated using scavenged samples from preterm infants - Wikidata - awgldk - TriplyDB

Population pharmacokinetics of metronidazole evaluated using scavenged samples from preterm infants

Population pharmacokinetics of metronidazole evaluated using scavenged samples from preterm infants

http://www.wikidata.org/entity/Q35867330

about

Determining population and developmental pharmacokinetics of metronidazole using plasma and dried blood spot samples from premature infants Strategic biomarkers for drug development in treating rare diseases and diseases in neonates and infants Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescents Predicting neonatal pharmacokinetics from prior data using population pharmacokinetic modeling.Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology Advances in pediatric pharmacology, therapeutics, and toxicology.Dosing in neonates: special considerations in physiology and trial design.Clinical trials of medicines in neonates: the influence of ethical and practical issues on design and conduct.Paediatric pharmacokinetics: key considerations.Adverse consequences of neonatal antibiotic exposure Population pharmacokinetics of piperacillin using scavenged samples from preterm infants Population pharmacokinetics and dosing optimization of teicoplanin in children with malignant haematological disease.Development of a Pediatric Physiologically-Based Pharmacokinetic Model of Clindamycin Using Opportunistic Pharmacokinetic Data.New antibiotic dosing in infants.Pharmacokinetic studies in infants using minimal-risk study designs White paper: recommendations on the conduct of superiority and organism-specific clinical trials of antibacterial agents for the treatment of infections caused by drug-resistant bacterial pathogens Essential medicines containing ethanol elevate blood acetaldehyde concentrations in neonates.Pragmatic pharmacology: population pharmacokinetic analysis of fentanyl using remnant samples from children after cardiac surgery.Optimizing operational efficiencies in early phase trials: The Pediatric Trials Network experience.Population Pharmacokinetics of Fluconazole in Premature Infants with Birth Weights Less than 750 Grams.An opportunistic study evaluating pharmacokinetics of sildenafil for the treatment of pulmonary hypertension in infants.The role of human cytochrome P450 enzymes in the formation of 2-hydroxymetronidazole: CYP2A6 is the high affinity (low Km) catalyst Developmental pharmacokinetics of piperacillin and tazobactam using plasma and dried blood spots from infants.Methods for pharmacokinetic analysis in young children.Dosing antibiotics in neonates: review of the pharmacokinetic data.Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design.Therapeutic guidelines for prescribing antibiotics in neonates should be evidence-based: a French national survey.Development of a Novel Multipenicillin Assay and Assessment of the Impact of Analyte Degradation: Lessons for Scavenged Sampling in Antimicrobial Pharmacokinetic Study Design.Potential of bisbenzimidazole-analogs toward metronidazole-resistant Trichomonas vaginalis isolates.Comparative Analysis of Ampicillin Plasma and Dried Blood Spot Pharmacokinetics in Neonates.Penetration of cefotaxime into cerebrospinal fluid in neonates and young infants.

P2860

Q24626231-7E0EAABF-BB48-449C-83F1-6AE693704F8E Q27024346-407E9D7B-8E48-4F50-9FEC-89A1E57AFA3D Q30832465-D67046CA-81F8-4434-BD70-092BECE6F30E Q30938796-9758984A-95B4-42E3-AEE2-4AEFAA017F17 Q33827819-02891374-D4FD-4F22-906D-CA62E7D89CDE Q33998667-586F93DE-10C5-4DB7-8C3A-21BC14CA4A74 Q34716879-6ACFA2D5-4338-479E-A9E0-481120A48092 Q35135932-AB6B9F59-B673-41AB-8154-CA36A919B31D Q35135940-BF96C0E8-352D-4F28-81E4-D8ACD8FB0F2F Q35926313-F7E65E7B-D199-49E7-87F7-61DFC273510B Q35965812-A4719308-F976-4176-A505-81A4BC00DCF9 Q36243693-F1CBE97E-90FB-4A5A-BD2D-2A00D48A1403 Q36307045-8A8991C0-BE62-458B-B259-A23AC1D19440 Q36438111-577A065E-7C3D-4814-9DB8-6F659E6525F3 Q36438116-42C4C3E3-CD0D-4998-9B82-564651FC72EA Q36854025-1D99450F-C6DA-4185-B71D-9E99D651FBE6 Q36906179-C95ACAB5-B5F0-4B1B-BA2C-AB323E2BB8A1 Q36924737-795CDE79-4C82-43D5-ABFD-D975D0D1DD34 Q37203671-58424A4C-B875-4BF6-8F53-123B7D7A0A0A Q37203784-9FE51069-401D-41AD-9EEC-9D97D1EB67AB Q37212142-46C8AA10-2837-4908-9691-4366474909FF Q37422732-8E5AA959-31C8-4A1A-B825-C66F8BA44B34 Q37713019-A5711C6B-F0AC-4231-8507-935359DD9AAD Q38187157-2C2F0554-4447-4A11-8AD4-5B56ED9E1800 Q38649419-638D8113-3326-42E3-9257-9E0B76F4B32A Q40848375-01B8BD98-6462-4C6F-B47E-2EC02E325791 Q41516160-5C216CEB-9A4C-4ED7-A08D-5A1CA75BD1B8 Q47689223-F90702F9-F831-4E5E-80F9-E162FD935D60 Q48122716-BB019C94-6542-4313-A11A-2487A0C501AA Q48559800-62066FA0-59D7-4231-A8DF-F1DCF30DAE38 Q50044338-1AB5AD06-1A15-44CE-9B57-90C52E8B72CB

P2860

Population pharmacokinetics of metronidazole evaluated using scavenged samples from preterm infants

http://www.wikidata.org/entity/Q35867330

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Population pharmacokinetics of ...... d samples from preterm infants

@ast

Population pharmacokinetics of ...... d samples from preterm infants

@en

type

label

Population pharmacokinetics of ...... d samples from preterm infants

@ast

Population pharmacokinetics of ...... d samples from preterm infants

@en

prefLabel

Population pharmacokinetics of ...... d samples from preterm infants

@ast

Population pharmacokinetics of ...... d samples from preterm infants

@en

P1433

Q35867330-BDFA94BC-F81B-41F4-81DB-3B89D07780ED

P1476

Q35867330-4F08A99B-5554-4F04-9733-A3F8313856B9

P2093

Q35867330-0FA6FDC1-DF42-4DF4-A738-C62DD51E56DD

Q35867330-1C6B0619-36F8-42FA-AB20-BD4CDBE11F18

Q35867330-4D5F257D-FEAD-444B-87B5-676F65B3D83A

Q35867330-828DA012-8035-4ED1-BBA8-442E501DC12D

Q35867330-831B9849-A2E6-4147-8EA3-6339F8E68B8D

Q35867330-8F290D2E-F272-4EFE-AF19-0D2EBD2EFC9E

Q35867330-AD126F84-B203-4333-8C21-A4A6AA6811F7

Q35867330-C70BE6C8-82E3-4ACF-B7AB-CB159F4601DA

Q35867330-D2119F0B-B16F-4F10-9948-7FFF1B0FDEFE

Q35867330-F28EBC98-1824-4F18-89A9-FBBDE5571E3D

P2860

Q35867330-0C0D6573-3D9D-4E80-B669-5D3CE0278CF2

Q35867330-20794796-0124-4C36-89E5-6414991920CF

Q35867330-26ACB482-EE3D-41B8-98B4-12F163B0B8DB

Q35867330-31FF1D74-E4F3-47BF-A1B4-31E7B01FFFE1

Q35867330-50350323-F225-426D-A18B-F6F01CECFB4B

Q35867330-885B0BE9-4CEA-447B-82BB-640810EF6A00

Q35867330-9FEBFC77-D027-4FAF-B9F8-6E56207AF4CF

Q35867330-A5BDE1B4-BDB4-42BA-9CE9-07C39D15455D

Q35867330-B2748EFE-8E44-4C2F-BE36-D0242EDFB4E1

Q35867330-C1C6A66D-6D9D-409D-AE48-DF3416ED8A5C

P304

Q35867330-258FB936-508F-4E7F-9C8F-EB11D345A216

P31

Q35867330-C2AFFAB7-D2CD-4069-8867-646A18256A33

P356

Q35867330-DE7D900B-0936-4FAE-83CA-68403548EC96

P407

Q35867330-E89E8593-851B-4333-ABB8-5D2DF5455BC4

P433

Q35867330-5E0F9C73-CE0C-4B57-85E0-B480E84EB119

P478

Q35867330-86588712-05B8-4FFE-874D-19D4FDEDB618

P577

Q35867330-05699C7D-DE9F-47CB-84B6-D9F95234B5F3

P5875

Q35867330-841A4882-AF38-441D-9999-7EA3C2DB992D

P698

Q35867330-7AE7AF9F-6021-4D77-A143-BCDE1F33C5AA

P921

Q35867330-ACEF79FD-199C-4351-8075-B7B9521F75D3

Q35867330-D2326BB8-923D-48E5-AA73-05222AD1A4C4

P932

Q35867330-B3FEA932-AC22-4EE8-B4F8-F15701FDEA77

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Population pharmacokinetics of ...... d samples from preterm infants

@en

P2093

Angela D M Kashuba

http://www.w3.org/2001/XMLSchema#string

Arlene Zadell

http://www.w3.org/2001/XMLSchema#string

Ashley Ross

http://www.w3.org/2001/XMLSchema#string

Daniel K Benjamin

http://www.w3.org/2001/XMLSchema#string

Daniele Ouellet

http://www.w3.org/2001/XMLSchema#string

Janice E Sullivan

http://www.w3.org/2001/XMLSchema#string

Laura P James

http://www.w3.org/2001/XMLSchema#string

Michael Cohen-Wolkowiez

http://www.w3.org/2001/XMLSchema#string

Michele C Walsh

http://www.w3.org/2001/XMLSchema#string

Nancy Newman

http://www.w3.org/2001/XMLSchema#string

P2860

Population pharmacokinetics of meropenem in plasma and cerebrospinal fluid of infants with suspected or complicated intra-abdominal infections

Population pharmacokinetics of fluconazole in young infants.

Evaluation of the nonparametric estimation method in NONMEM VI: application to real data.

Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.

Population pharmacokinetic analysis of vancomycin in neonates. A new proposal of initial dosage guideline.

Intravenous metronidazole in the newborn

Development of a liquid chromatography-tandem mass spectrometry assay of six antimicrobials in plasma for pharmacokinetic studies in premature infants.

Pharmacokinetics and metabolism of oral midazolam in preterm infants.

Necrotizing enterocolitis in newborns: pathogenesis, prevention and management.

Bacteremia due to anaerobic bacteria in newborns.

P304

1828-1837

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.06071-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221754759

http://www.w3.org/2001/XMLSchema#string

P698

22252819

http://www.w3.org/2001/XMLSchema#string

P921

P932

3318328

http://www.w3.org/2001/XMLSchema#string